Lexicon Pharmaceuticals Reports Q3 2026 Revenue of $11.3 Million
Lexicon reported a net loss of $14.0 million, or $0.03 per share, and ended September with $183.2 million in cash and investments. Revenue was $11.3 million, compared with $14.2 million a year earlier.
Lexicon Pharmaceuticals reported third-quarter 2026 revenue of $11.3 million, compared with $14.2 million a year earlier. The company posted a net loss of $14.0 million, or $0.03 per share, and ended September with $183.2 million in cash and investments. Lexicon also reported progress across its cl…